Management of schizophrenia in children and adolescents. The role of clozapine (Q34006420)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Management of schizophrenia in children and adolescents. The role of clozapine	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Management of schizophrenia in children and adolescents. The role of clozapine (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

1 reference

based on heuristic

inferred from title

Helmut Remschmidt

1

object named as

Remschmidt H

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Fleischhaker C

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hennighausen K

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Schulz E

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pediatric Drugs

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

253-262

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

https://scigraph.springernature.com/pub.10.2165/00128072-200002040-00002

0 references

Drug treatment of resistant schizophrenia. Limitations and recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine-induced transient white blood count disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine for the treatment of adolescents with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effects of clozapine. A 4-year follow-up of a controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine treatment in very early onset schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine in the treatment of a young adolescent with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine-associated agranulocytosis: risk and aetiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

More on clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

General pharmacology of clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine: guidelines for clinical management

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood biogenic amines during clozapine treatment of early-onset schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine-related seizures: experience with 5,629 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EEG changes and seizures with clozapine medication in schizophrenic adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European experience with use of clozapine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Results of treatment with clozapine in schizophrenic adolescents]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dimensions of outcome with clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple-outcome criteria in schizophrenia: an overview of outcome with clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine in treatment-resistant schizophrenics

1 reference

https://pubmed.ncbi.nlm.nih.gov/10946414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00128072-200002040-00002

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34006420&oldid=1952308777"